Clinical Trials Logo

Advanced Liver Cancer clinical trials

View clinical trials related to Advanced Liver Cancer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03484962 Withdrawn - Clinical trials for Advanced Liver Cancer

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Start date: March 25, 2018
Phase: Phase 2
Study type: Interventional

This is a phase II Randomized comparison clinical trial of activated CIK armed with anti-CD3-MUC1 bispecific antibody for advanced liver cancer. And the aim of this research is to study the clinical efficacy and safety of activated CIK armed with anti-CD3-MUC1 bispecific antibody for liver cancer.